News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
880,151 Results
Type
Article (88590)
Company Profile (815)
Press Release (790712)
Multimedia
Podcasts (228)
Webinars (34)
Section
Business (233513)
Career Advice (4158)
Deals (39950)
Drug Delivery (172)
Drug Development (91615)
Employer Resources (207)
FDA (18517)
Job Trends (17472)
News (398529)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (39)
Allergies (184)
Alliances (56987)
ALS (222)
Alzheimer's disease (1926)
Antibody-drug conjugate (ADC) (491)
Approvals (18798)
Artificial intelligence (804)
Autoimmune disease (302)
Automation (59)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (486)
Bladder cancer (196)
Brain cancer (80)
Breast cancer (791)
Cancer (6125)
Cardiovascular disease (522)
Career advice (3590)
Career pathing (48)
CAR-T (354)
CDC (75)
Celiac Disease (3)
Cell therapy (989)
Cervical cancer (48)
Clinical research (78371)
Collaboration (2239)
Company closure (8)
Compensation (1417)
Complete response letters (100)
COVID-19 (3028)
CRISPR (119)
C-suite (1181)
Cystic fibrosis (162)
Data (7919)
Decentralized trials (3)
Denatured (86)
Depression (185)
Dermatology (85)
Diabetes (630)
Diagnostics (7499)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (392)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (302)
Earnings (102085)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137443)
Executive appointments (1155)
FDA (22357)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1839)
Gene editing (259)
Generative AI (85)
Gene therapy (808)
GLP-1 (1242)
Government (5539)
Grass and pollen (8)
Guidances (412)
Healthcare (21084)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (344)
Immuno-oncology (100)
Indications (181)
Infectious disease (3401)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (299)
Interviews (820)
IPO (17990)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (111)
Layoffs (678)
Leadership (49)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (803)
Lymphoma (435)
Machine learning (63)
Management (66)
Manufacturing (1124)
MASH (202)
Medical device (15221)
Medtech (15337)
Mergers & acquisitions (23211)
Metabolic disorders (1678)
mRNA (242)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (464)
Neuropsychiatric disorders (124)
Neuroscience (3563)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (78)
Obesity (815)
Opinion (366)
Ovarian cancer (222)
Pain (272)
Pancreatic cancer (309)
Parkinson's disease (384)
Partnered (39)
Patents (622)
Patient recruitment (693)
Peanut (67)
People (67718)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24211)
Phase 2 (34044)
Phase 3 (25606)
Pipeline (8528)
Policy (383)
Postmarket research (3558)
Preclinical (10896)
Press Release (72)
Prostate cancer (310)
Psychedelics (68)
Radiopharmaceuticals (351)
Rare diseases (1182)
Real estate (7457)
Recruiting (81)
Regulatory (30046)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (312)
Series B (224)
Service/supplier (30)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (188)
Sponsored (54)
Startups (4362)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (139)
Vaccines (1263)
Venture capital (122)
Weight loss (561)
Women's health (129)
Worklife (24)
Date
Today (255)
Last 7 days (1002)
Last 30 days (3542)
Last 365 days (33164)
2026 (12500)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (100)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (52057)
Australia (9156)
California (13599)
Canada (3829)
China (1430)
Colorado (588)
Connecticut (601)
Delaware (417)
Europe (120014)
Florida (2016)
Georgia (443)
Hawaii (4)
Idaho (69)
Illinois (1166)
India (97)
Indiana (634)
Iowa (25)
Japan (542)
Kansas (139)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1667)
Massachusetts (9941)
Michigan (409)
Minnesota (759)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3628)
New Mexico (34)
New York (3572)
North Carolina (1845)
North Dakota (10)
Northern California (6697)
Ohio (421)
Oklahoma (26)
Oregon (55)
Pennsylvania (2707)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5319)
Tennessee (216)
Texas (2197)
United States (48780)
Utah (408)
Vermont (1)
Virginia (349)
Washington D.C. (88)
Washington State (1125)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
There are 880,151 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Gilead laying off vast majority of Arcellx employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
May 8, 2026
·
51 min read
·
BioSpace Editorial Staff
Earnings
Gilead sets blockbuster bar for Yeztugo’s first full year on the market
With initial patients coming back for their second dose of Gilead’s twice-yearly PrEP injection, the pharma thinks the shot will hit $1 billion in sales this year, serving as “a cornerstone in Gilead’s revenue growth story.”
May 8, 2026
·
2 min read
·
Tristan Manalac
Pipeline
Ascendis retreats to rare endocrinology wheelhouse as cancer plans falter
Before discontinuing the asset, Ascendis Pharma was studying onvapegleukin alfa in advanced or metastatic solid tumors, demonstrating a three- to four-month overall survival advantage over historical controls.
May 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
May 8, 2026
·
3 min read
Press Releases
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to ‘RZ-001' for Hepatocellular Carcinoma
May 8, 2026
·
3 min read
Press Releases
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease
May 8, 2026
·
18 min read
Press Releases
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026
·
2 min read
Press Releases
Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87
May 8, 2026
·
5 min read
Press Releases
InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren’s Syndrome in China
May 8, 2026
·
3 min read
Press Releases
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026
·
4 min read
1 of 88,016
Next
